{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:19:46Z","timestamp":1787066386044,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaci.2021.06.018","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T07:11:42Z","timestamp":1628061102000},"page":"283-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease"],"prefix":"10.1016","volume":"148","author":[{"given":"Rubaiyat","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.06.018_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2500\/108854193778773985","article-title":"Widal on the aspirin triad and induction of tolerance","volume":"14","author":"Klion","year":"1993","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2021.06.018_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0021-8707(67)90076-7","article-title":"Concerning the nature of intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib7","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2500\/ajra.2012.26.3738","article-title":"Aspirin-exacerbated respiratory disease in China: a cohort investigation and literature review","volume":"26","author":"Fan","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2016.11.021","article-title":"Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease","volume":"5","author":"Jerschow","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.06.018_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2016.05.048","article-title":"Automated identification of an aspirin-exacerbated respiratory disease cohort","volume":"139","author":"Cahill","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaip.2015.01.007","article-title":"Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease","volume":"3","author":"Lee-Sarwar","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2222.1988.tb02838.x","article-title":"Aspirin-induced asthma as a viral disease","volume":"18","author":"Szczeklik","year":"1988","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaip.2016.05.016","article-title":"Aspirin-exacerbated respiratory disease: not always \u201cadult-onset\u201d","volume":"4","author":"Tuttle","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1749-4486.2012.02527.x","article-title":"Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit","volume":"37","author":"Abdalla","year":"2012","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaci.2021.06.018_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S0022215108003319","article-title":"Spectrum of nasal disease in an asthma clinic: when is an ENT opinion indicated?","volume":"123","author":"Stanton","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jaci.2021.06.018_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00405-016-4366-x","article-title":"Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study","volume":"274","author":"Gudziol","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaci.2021.06.018_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2500\/ajr.2007.21.3108","article-title":"Long-term outcome analysis of endoscopic sinus surgery for chronic sinusitis","volume":"21","author":"Young","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2021.06.018_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Ta","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1081-1206(10)61323-3","article-title":"Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease","volume":"94","author":"Mascia","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lary.23610","article-title":"Role of frontal sinus surgery in nasal polyp recurrence","volume":"123","author":"Bassiouni","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2021.06.018_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter\u2019s triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jaci.2021.06.018_bib24","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/lary.20653","article-title":"Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis","volume":"119","author":"Hopkins","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2021.06.018_bib25","first-page":"277","article-title":"Does time from previous surgery predict subsequent treatment failure in chronic rhinosinusitis with nasal polyps?","volume":"59","author":"Hopkins","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2021.06.018_bib26","doi-asserted-by":"crossref","unstructured":"Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, et\u00a0al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial [published online ahead of print April 16, 2021]. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(21)00097-7.","DOI":"10.1016\/S2213-2600(21)00097-7"},{"key":"10.1016\/j.jaci.2021.06.018_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2500\/ajr.2007.21.2909","article-title":"Intracranial polyps in patients with Samter\u2019s triad","volume":"21","author":"Majithia","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2021.06.018_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/464958","article-title":"Bilateral inflammatory aural polyps: a manifestation of Samter\u2019s triad","volume":"2009","author":"Brobst","year":"2009","journal-title":"Int J Otolaryngol"},{"key":"10.1016\/j.jaci.2021.06.018_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/MAO.0b013e318259522f","article-title":"Aural polyps in Samter\u2019s triad: case report and literature review","volume":"33","author":"Shen","year":"2012","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.jaci.2021.06.018_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/all.12941","article-title":"Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2LEN) survey","volume":"71","author":"Makowska","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.rmed.2005.05.017","article-title":"Characterisation of patients with frequent exacerbation of asthma","volume":"100","author":"Koga","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaip.2020.11.051","article-title":"Aspirin-exacerbated respiratory disease: association between patient-reported sinus and asthma morbidity","volume":"9","author":"Bergmark","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib35","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2020.11.001","article-title":"Inflammatory heterogeneity in aspirin-exacerbated respiratory disease","volume":"147","author":"Scott","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/all.14141","article-title":"Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis","volume":"75","author":"Celejewska-W\u00f3jcik","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaip.2018.10.032","article-title":"A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease","volume":"7","author":"DeGregorio","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaip.2019.02.037","article-title":"Sinus surgery improves lower respiratory reactivity during aspirin desensitization for AERD","volume":"7","author":"Huang","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)61150-7","article-title":"The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease","volume":"95","author":"White","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2021.06.018_bib43","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jaip.2018.12.014","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","volume":"7","author":"Jerschow","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2007.03.020","article-title":"The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges","volume":"120","author":"Williams","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib45","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jaip.2018.11.017","article-title":"Accidental ingestion of aspirin and nonsteroidal anti-inflammatory drugs is common in patients with aspirin-exacerbated respiratory disease","volume":"7","author":"Kiladejo","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","article-title":"Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma","volume":"84","author":"Settipane","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib47","author":"Woessner"},{"key":"10.1016\/j.jaci.2021.06.018_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)61378-6","article-title":"Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"97","author":"El Miedany","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2013.10.057","article-title":"Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: meta-analysis of controlled clinical trials","volume":"134","author":"Morales","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1081\/JAS-120026063","article-title":"Safety of selective COX-2 inhibitors in aspirin\/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib","volume":"41","author":"Bavbek","year":"2004","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2021.06.018_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000096000","article-title":"Safety of meloxicam in aspirin-hypersensitive patients with asthma and\/or nasal polyps\u2014a challenge-proven study","volume":"142","author":"Bavbek","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib52","first-page":"393","article-title":"Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs","volume":"35","author":"Senna","year":"2003","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1183\/09031936.93.03050535","article-title":"Choline magnesium trisalicylate in patients with aspirin-induced asthma","volume":"3","author":"Szczeklik","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.06.018_bib54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2222.1990.tb02703.x","article-title":"Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients","volume":"20","author":"Nizankowska","year":"1990","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0194599814555836","article-title":"Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study","volume":"152","author":"Sommer","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2021.06.018_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/alr.21678","article-title":"A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial","volume":"6","author":"Sommer","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2021.06.018_bib57","first-page":"303","article-title":"Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study","volume":"57","author":"Philpott","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2021.06.018_bib58","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Cardet","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib59","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/alr.22168","article-title":"Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease","volume":"8","author":"Glicksman","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2021.06.018_bib60","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaip.2018.09.012","article-title":"A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease","volume":"7","author":"Eid","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib61","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jaip.2020.04.017","article-title":"A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease","volume":"8","author":"Chen","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaip.2016.04.028","article-title":"Eosinophilia-associated coronary artery vasospasm in patients with aspirin-exacerbated respiratory disease","volume":"4","author":"Shah","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib63","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.jaip.2020.06.061","article-title":"Leukotriene-associated rash in aspirin-exacerbated respiratory disease","volume":"8","author":"Laidlaw","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/crj.12154","article-title":"Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients","volume":"9","author":"Y\u0131lmaz","year":"2015","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jaci.2021.06.018_bib65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaip.2017.07.006","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss vasculitis) presenting as Samter\u2019s triad","volume":"6","author":"Ameratunga","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib66","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1945892420903587","article-title":"Aspirin-exacerbated respiratory disease with allergic fungal rhinosinusitis: a case series of overlapping sinonasal endotypes","volume":"34","author":"Studer","year":"2020","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib67","first-page":"144","article-title":"The relationship between subjective assessment instruments in chronic rhinosinusitis","volume":"45","author":"Lim","year":"2007","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2021.06.018_bib68","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaci.2015.10.012","article-title":"Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment","volume":"136","author":"Rudmik","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-4486.2006.01155.x","article-title":"A review of sinonasal outcome scoring systems\u2014which is best?","volume":"31","author":"Morley","year":"2006","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaci.2021.06.018_bib70","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaci.2021.06.018_bib71","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/jcm9040925","article-title":"Associations between the quality of life and nasal polyp size in patients suffering from chronic rhinosinusitis without nasal polyps, with nasal polyps or aspirin-exacerbated respiratory disease","volume":"9","author":"Schneider","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib72","first-page":"358","article-title":"Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis","volume":"57","author":"Ta","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2021.06.018_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2021.06.018_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2273.1995.tb00007.x","article-title":"Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide","volume":"20","author":"Lildholdt","year":"1995","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.jaci.2021.06.018_bib75","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.06.018_bib76","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/alr.22194","article-title":"High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis","volume":"8","author":"McHugh","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2021.06.018_bib77","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/lary.21969","article-title":"Evidence for distinct histologic profile of nasal polyps with and without eosinophilia","volume":"121","author":"Payne","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2021.06.018_bib78","first-page":"183","article-title":"Mackay IS. Staging in rhinosinusitus","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2021.06.018_bib79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1945892420923926","article-title":"Computed tomography findings can help identify different chronic rhinosinusitis with nasal polyp phenotypes","volume":"34","author":"Roland","year":"2020","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib80","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.anai.2016.09.439","article-title":"Association of severity of chronic rhinosinusitis with degree of comorbid asthma control","volume":"117","author":"Phillips","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.coi.2020.10.004","article-title":"Biologic treatment options for severe asthma","volume":"66","author":"Hearn","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib83","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib84","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.chest.2020.03.042","article-title":"Real-world effectiveness and the characteristics of a \u201csuper-responder\u201d to mepolizumab in severe eosinophilic asthma","volume":"158","author":"Kavanagh","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2021.06.018_bib86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chest.2020.08.2083","article-title":"Real world effectiveness of benralizumab in severe eosinophilic asthma","volume":"159","author":"Kavanagh","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2021.06.018_bib87","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib88","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1034\/j.1398-9995.2002.t01-1-13447.x","article-title":"Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA)","volume":"57","author":"Alonso-Llamazares","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib89","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cea.12110","article-title":"Nasal lysine aspirin challenge in the diagnosis of aspirin-exacerbated respiratory disease: asthma and rhinitis","volume":"43","author":"Miller","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.06.018_bib90","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","article-title":"Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma","volume":"15","author":"Nizankowska","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.06.018_bib91","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60012-9","article-title":"Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib92","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","article-title":"Selection of patients for aspirin desensitization treatment","volume":"118","author":"Stevenson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib93","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaip.2015.06.013","article-title":"An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease","volume":"3","author":"Chen","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib94","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaip.2018.08.004","article-title":"Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease","volume":"7","author":"Pelletier","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.anai.2018.05.007","article-title":"Omalizumab can inhibit respiratory reaction during aspirin desensitization","volume":"121","author":"Lang","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.018_bib96","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.201906-1215OC","article-title":"Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease. A\u00a0randomized controlled trial","volume":"201","author":"Hayashi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib97","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jaip.2020.09.007","article-title":"Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: a case series","volume":"9","author":"Martin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.018_bib98","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.06.018_bib99","doi-asserted-by":"crossref","unstructured":"Hopkins C, McKenzie JL, Anari S, Carrie S, Ramakrishnan Y, Kara N, et\u00a0al. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps [published online ahead of print April 5, 2021]. Clin Otolaryngol. https:\/\/doi.org\/10.1111\/coa.13779.","DOI":"10.1111\/coa.13779"},{"key":"10.1016\/j.jaci.2021.06.018_bib100","first-page":"333","article-title":"The burden of non-steroidal anti-inflammatory exacerbated respiratory disease from the patient\u2019s perspective\u2014a qualitative analysis of posts from the Samter\u2019s Society","volume":"58","author":"Alanin","year":"2020","journal-title":"Rhinology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921009751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921009751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:31:43Z","timestamp":1758792703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921009751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0091674921009751"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.06.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}